Rui Kang Pharmaceutical Group Investments Limited announced that Mr. Gao Yongping has been appointed as a non-executive Director with effect from 18 April 2017. The board further announced that Ms. Chen Miaoping has tendered her resignation as an executive director and the chief executive officer of the company with effect from April 30, 2017 due to her personal and other business commitments which require more of her dedication and Mr. Leung Pak Hou Anson, the executive Director, will be appointed as the chief executive officer with effect from April 30, 2017 following the resignation of Ms. Chen. Mr. Leung is an executive director and joined group in May 2013.

He is also the compliance officer of the company.